USD10
CATX Ações
Conheça: Perspective TherapeuticsPerspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
USD10
CATX Ações
Conheça: Perspective TherapeuticsPerspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Estatísticas
JANELA DE NEGOCIAÇÃO
Aberta
FECHA ÀS
20:00 GMT+0
CAPITALIZAÇÃO DE MERCADO
US$ 479,09 mi
PREÇO DE ABERTURA
US$ 4,44
MÍNIMA (1 ano)
US$ 1,60
MÁXIMA (1 ano)
US$ 6,16
MÍNIMA (24 horas)
US$ 4,21
MÁXIMA (24 horas)
US$ 4,60
VOLUME (24 horas)
US$ 427,48 mil
54,6%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | US$ 4,44 | |
1 dia | US$ 4,53 |